Menu visibility control

Video

Events

Startup Surgery

Most Recent

Need to Know

Therapist bots: AI and mental health

News

Startup Weekly: Desolenator wins Pitch@Palace 7.0, Startupbootcamp IoT calls for applications and more

Investments

PropTech startup YourWelcome raises £1m to help Airbnb hosts

Press Releases

Peer-to-peer lender Kuflink receives full FCA authorisation
Mention Me win best tech startup award at Drapers Digital Festival
GamCrowd officially launches the first ever Gambling Tech Week as part of London Tech Week

Cambridge-based Healx secures £1.5m Series A to combat rare diseases

medication
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

HealthTech startup Healx has secured a £1.5m Series A round from Amadeus Capital and Jonathan Milner, a healthcare entrepreneur.

The Cambridge-based firm, which uses machine learning and advanced data analytics, seeks to find new uses for existing drugs in an attempt to combat rare diseases.

Hermann Hauser, partner and co-founder of Amadeus Capital Partners, said: “Healx has taken advances in machine learning, data mining and analytics and combined them with deep pharma and life sciences expertise to address a growing need in the healthcare sector.

Tech in Cambridge: A successful hub with a marketing problem

“With huge pressure on R&D budgets, drug repositioning will be essential in the fight against rare diseases,” he added.

Healx’s technology platform matches potential treatments to rare conditions and patients. The company aims to complete its drug repurposing studies within six months.

Tim Guilliams, founder & CEO at Healx, commented: “Studies into rare medical conditions have long failed to receive adequate funding.”

The firm says it will use the money to expand its technology platform and accelerate the drug review process, in hope to find treatments to more illnesses.

“By repurposing existing drugs to combat rare diseases, Healx is able to find potential treatments at a fraction of the cost and in a much shorter timeframe than developing a new drug,” Guilliams concluded.

Enter your email address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

AI chatbots mental health

Therapist bots: AI and mental health
posted 8 hours ago

Startup Weekly

Startup Weekly: Desolenator wins Pitch@Palace 7.0, Startupbootcamp IoT calls for applications and more
posted on April 28, 2017

Henry Bennett

PropTech startup YourWelcome raises £1m to help Airbnb hosts
posted on April 28, 2017

people with tech

£94m in UK tech investment, Uber’s sick pay u-turn, a chameleon car and more in The Week in Tech
posted on April 28, 2017

Richard Goold AI jobs

Tech chats: AI’s impact on jobs with EY’s Richard Goold
posted on April 27, 2017

Investment

Data science firm Exonar raises £1.25m to expand across Europe
posted on April 27, 2017